Pfizer Covid Pill Revenue Plunges 95%. The Stock Is Rising Anyway. - barrons.com

Pfizer Covid Pill Revenue Plunges 95%. The Stock Is Rising Anyway. - barrons.com
Business

Listen to this article

0%

Pfizerlifted the bottom end of its full-year revenue guidance on Tuesday, citing growth in its non-Covid pharmaceutical portfolio. Its smaller Covid vaccine partner offered a less optimistic outlook.… [+99 chars]

Leave A Comment

Comments are moderated and may take time to appear.

Comments

No comments yet. Be the first to comment!

Stay Connected